Date	Chamber	Action
3/10/2023	House	Rule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance

New Act

Synopsis As Introduced
Creates the Canadian Prescription Drug Importation Act. Provides that the Department of Public Health shall establish the Canadian prescription drug importation program for the importation of safe and effective prescription drugs from Canada which have the highest potential for cost savings to the State. Provides that the Department shall contract with a vendor to provide services under the program. Provides that by December 1, 2023, and each year thereafter, the vendor shall develop a wholesale prescription drug importation list identifying the prescription drugs that have the highest potential for cost savings to the State. Provides that the vendor shall identify Canadian suppliers that are in full compliance with the provisions of the Act and contract with the Canadian suppliers to import drugs under the program. Contains provisions concerning: a bond requirement; requirements for eligible prescription drugs; requirements for eligible Canadian suppliers; requirements for eligible importers; distribution requirements; federal approval; prescription drug supply chain documentation; immediate suspension of specified imported drug; requirements of an annual report; and notification of federal approval. Provides that the Department shall adopt rules necessary to implement the Act.

Actions 

Date	Chamber	Action
2/17/2023	House	Filed with the Clerk by Rep. Hoan Huynh
2/17/2023	House	First Reading
2/17/2023	House	Referred to Rules Committee
2/28/2023	House	Assigned to Prescription Drug Affordability & Accessibility Committee
3/10/2023	House	Rule 19(a) / Re-referred to Rules Committee

Back To Top